- Home
- CSBR vs SRTS Comparison
CSBR vs SRTS Comparison
Compare CSBR & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- SRTS
- Stock Information
- Founded
- CSBR 1985
- SRTS 2010
- Country
- CSBR United States
- SRTS United States
- Employees
- CSBR N/A
- SRTS N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- SRTS Medical/Dental Instruments
- Sector
- CSBR Health Care
- SRTS Health Care
- Exchange
- CSBR Nasdaq
- SRTS Nasdaq
- Market Cap
- CSBR 98.1M
- SRTS 106.0M
- IPO Year
- CSBR 1986
- SRTS 2016
- Fundamental
- Price
- CSBR $7.55
- SRTS $7.10
- Analyst Decision
- CSBR Strong Buy
- SRTS Strong Buy
- Analyst Count
- CSBR 1
- SRTS 2
- Target Price
- CSBR $8.00
- SRTS $12.50
- AVG Volume (30 Days)
- CSBR 61.8K
- SRTS 190.3K
- Earning Date
- CSBR 12-11-2024
- SRTS 02-06-2025
- Dividend Yield
- CSBR N/A
- SRTS N/A
- EPS Growth
- CSBR N/A
- SRTS N/A
- EPS
- CSBR N/A
- SRTS 0.57
- Revenue
- CSBR $53,571,000.00
- SRTS $41,308,000.00
- Revenue This Year
- CSBR $14.19
- SRTS $65.04
- Revenue Next Year
- CSBR $10.11
- SRTS $24.87
- P/E Ratio
- CSBR N/A
- SRTS $12.48
- Revenue Growth
- CSBR 7.19
- SRTS 65.62
- 52 Week Low
- CSBR $3.60
- SRTS $2.15
- 52 Week High
- CSBR $7.85
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- CSBR 71.57
- SRTS 32.61
- Support Level
- CSBR $4.61
- SRTS $8.30
- Resistance Level
- CSBR $7.85
- SRTS $9.07
- Average True Range (ATR)
- CSBR 0.75
- SRTS 0.43
- MACD
- CSBR 0.26
- SRTS -0.25
- Stochastic Oscillator
- CSBR 81.84
- SRTS 1.78
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.